Recognition by the CD8+ T cell receptor (TCR) of immunogenic peptide (p) presented by class I major histocompatibility complexes (MHC) is a key event in the specific immune response against virus-infected cells or tumor cells. The gene discussed is CD8A; the disease is neoplasm.